Join
Live feed
·
PRReleasevia Quantisnow
Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Corporate Updates

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MIST (Milestone Pharmaceuticals Inc.) and more on Quantisnow.